KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+3.25%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$544M
AUM Growth
+$544M
(+2.9%)
Cap. Flow
+$2.34M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
37.65%
Holding
137
New
1
Increased
17
Reduced
30
Closed
3
Top Buys
| 1 |
Southwest Airlines
LUV
|
$8.98M |
| 2 |
JPMorgan Chase
JPM
|
$386K |
| 3 |
PepsiCo
PEP
|
$275K |
| 4 |
Aptiv
APTV
|
$156K |
| 5 |
Merck
MRK
|
$137K |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$3.95M |
| 2 |
Apple
AAPL
|
$1.12M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
$657K |
| 4 |
Broadridge
BR
|
$470K |
| 5 |
Alphabet (Google) Class C
GOOG
|
$385K |
Sector Composition
| 1 | Technology | 23.82% |
| 2 | Healthcare | 18.35% |
| 3 | Financials | 18.34% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Southwest Airlines
LUV
$17.3B
| $8.98M | 1.65% | +176,500 | New | +$8.98M |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.7M | 1.6% | 25,225 +300 | +1% | +$103K |
|
28
Chevron
CVX
$324B
| $8.68M | 1.6% | 68,646 -250 | -0.4% | -$31.6K |
|
|
29
Merck
MRK
$210B
| $8.4M | 1.54% | 138,310 +2,250 | +2% | +$137K |
|
30
Salesforce
CRM
$245B
| $7.7M | 1.42% | 56,475 | – | – |
|
|
31
JPMorgan Chase
JPM
$829B
| $7.28M | 1.34% | 69,910 +3,700 | +6% | +$386K |
|
32
Edwards Lifesciences
EW
$47.8B
| $7.15M | 1.31% | 49,100 | – | – |
|
|
33
Alphabet (Google) Class C
GOOG
$2.58T
| $6.63M | 1.22% | 5,942 -345 | -5% | -$385K |
|
34
Cisco
CSCO
$274B
| $6.6M | 1.21% | 153,376 -4,550 | -3% | -$196K |
|
35
Halliburton
HAL
$19.4B
| $6.25M | 1.15% | 138,675 -75 | -0.1% | -$3.38K |
|
36
Applied Materials
AMAT
$128B
| $4.56M | 0.84% | 98,805 +1,500 | +2% | +$69.3K |
|
37
Procter & Gamble
PG
$368B
| $3.08M | 0.57% | 39,455 | – | – |
|
38
Aflac
AFL
$57.2B
| $3.07M | 0.56% | 71,268 -1,980 | -3% | -$85.2K |
|
39
AbbVie
ABBV
$372B
| $2.32M | 0.43% | 25,045 -100 | -0.4% | -$9.27K |
|
40
Gilead Sciences
GILD
$140B
| $2.1M | 0.39% | 29,605 | – | – |
|
41
Vertex Pharmaceuticals
VRTX
$100B
| $2.01M | 0.37% | 11,827 -1,520 | -11% | -$258K |
|
42
3M
MMM
$82.8B
| $1.93M | 0.35% | 9,792 | – | – |
|
|
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.91M | 0.35% | 27,574 | – | – |
|
44
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.86M | 0.34% | 1,475 | – | – |
|
45
Exxon Mobil
XOM
$487B
| $1.84M | 0.34% | 22,241 -27 | -0.1% | -$2.23K |
|
46
Verizon
VZ
$186B
| $1.54M | 0.28% | 30,675 | – | – |
|
|
CYS.PRB
47
DELISTED
CYS Investments, Inc.
CYS.PRB
| $1.54M | 0.28% | 63,050 | – | – |
|
|
48
DuPont de Nemours
DD
$32.2B
| $1.49M | 0.27% | 22,575 -60,000 | -73% | -$3.95M |
|
49
B&G Foods
BGS
$361M
| $1.14M | 0.21% | 38,100 | – | – |
|
50
GE Aerospace
GE
$292B
| $1.04M | 0.19% | 76,298 | – | – |
|